Variant report
Variant | rs2198452 |
---|---|
Chromosome Location | chr11:59191240-59191241 |
allele | G/T |
Outlinks | Ensembl   UCSC |
- TF binding region (count:2)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:2 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | MAFF | chr11:59191240-59191333 | HepG2 | liver: | n/a | chr11:59191285-59191303 |
2 | MAFK | chr11:59191177-59191377 | HepG2 | liver: | n/a | chr11:59191291-59191302 chr11:59191286-59191302 chr11:59191291-59191302 |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
OR5A2 | TF binding region |
rs_ID | r2[population] |
---|---|
rs10792241 | 0.87[AFR][1000 genomes];0.95[AMR][1000 genomes];0.89[EUR][1000 genomes];0.95[ASN][1000 genomes] |
rs11230020 | 0.81[MEX][hapmap] |
rs12278910 | 0.81[MEX][hapmap] |
rs12289921 | 0.81[MEX][hapmap] |
rs1349776 | 0.95[AFR][1000 genomes] |
rs1377558 | 1.00[CHB][hapmap];1.00[JPT][hapmap];0.88[AFR][1000 genomes];1.00[AMR][1000 genomes];0.89[EUR][1000 genomes];0.95[ASN][1000 genomes] |
rs1453543 | 1.00[CHB][hapmap];1.00[CHD][hapmap];1.00[GIH][hapmap];1.00[JPT][hapmap];0.92[LWK][hapmap];1.00[MEX][hapmap];1.00[TSI][hapmap];0.80[YRI][hapmap];0.85[AFR][1000 genomes];0.91[AMR][1000 genomes];0.89[EUR][1000 genomes];0.95[ASN][1000 genomes] |
rs1453545 | 0.85[AFR][1000 genomes];0.91[AMR][1000 genomes];0.89[EUR][1000 genomes];0.95[ASN][1000 genomes] |
rs1453553 | 1.00[CHB][hapmap];1.00[JPT][hapmap];0.80[YRI][hapmap];0.87[AFR][1000 genomes];1.00[AMR][1000 genomes];0.89[EUR][1000 genomes];0.95[ASN][1000 genomes] |
rs1522757 | 1.00[CHD][hapmap] |
rs1530995 | 0.90[MEX][hapmap] |
rs17153732 | 1.00[CHB][hapmap];1.00[CHD][hapmap];1.00[GIH][hapmap];1.00[JPT][hapmap];0.90[MEX][hapmap] |
rs17153766 | 1.00[CHB][hapmap];1.00[CHD][hapmap];1.00[GIH][hapmap];1.00[JPT][hapmap];1.00[MEX][hapmap];0.95[ASN][1000 genomes] |
rs17153910 | 0.81[MEX][hapmap] |
rs17153962 | 0.90[MEX][hapmap] |
rs2100403 | 0.82[AFR][1000 genomes] |
rs2187530 | 0.85[CHD][hapmap] |
rs2219071 | 1.00[CHB][hapmap] |
rs486952 | 0.90[MEX][hapmap] |
rs495564 | 0.81[MEX][hapmap] |
rs559150 | 0.90[MEX][hapmap] |
rs567994 | 0.81[MEX][hapmap] |
rs6591541 | 0.81[MEX][hapmap] |
rs7108052 | 0.83[AFR][1000 genomes];0.89[EUR][1000 genomes] |
rs7120664 | 0.83[YRI][hapmap];0.88[AFR][1000 genomes];1.00[AMR][1000 genomes];0.89[EUR][1000 genomes];0.95[ASN][1000 genomes] |
rs8280 | 0.81[MEX][hapmap] |
rs9988824 | 0.98[AMR][1000 genomes];0.89[EUR][1000 genomes];0.87[ASN][1000 genomes] |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | nsv1050013 | chr11:58394598-59221090 | Active TSS Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer ZNF genes & repeats Genic enhancers Strong transcription Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 67 gene(s) | inside rSNPs | diseases |
2 | nsv1046084 | chr11:59034871-59314519 | Enhancers Active TSS Flanking Active TSS Weak transcription ZNF genes & repeats Bivalent Enhancer Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 24 gene(s) | inside rSNPs | diseases |
3 | nsv1047952 | chr11:59124719-59221606 | Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Active TSS ZNF genes & repeats | TF binding regionCpG islandChromatin interactive region | 6 gene(s) | inside rSNPs | diseases |
No data |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:59190400-59191400 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
2 | chr11:59191200-59191600 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |